{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T21:36:11Z","timestamp":1765316171350,"version":"3.46.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jdcr.2025.07.019","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T01:19:04Z","timestamp":1755652744000},"page":"65-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Progression of mycosis fungoides in a patient receiving a Janus kinase inhibitor"],"prefix":"10.1016","volume":"65","author":[{"given":"Julia M.","family":"Stankiewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette M.","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerle A.","family":"Merkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanne","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patty M.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5872-4613","authenticated-orcid":false,"given":"Maarten H.","family":"Vermeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1900-4322","authenticated-orcid":false,"given":"Rosanne","family":"Ottevanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdcr.2025.07.019_bib1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: the promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.07.019_bib3","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/jdv.19408","article-title":"Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib","volume":"38","author":"Cohen","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdcr.2025.07.019_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/ced\/llac124","article-title":"A case of S\u00e9zary syndrome in a patient during treatment with baricitinib for seronegative rheumatoid arthritis","volume":"48","author":"Saito","year":"2023","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.jdcr.2025.07.019_bib5","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jdcr.2025.07.019_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-023-02721-6","article-title":"A wide spectrum of phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review","volume":"18","author":"Maccora","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"26","key":"10.1016\/j.jdcr.2025.07.019_bib7","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood.2021013379","article-title":"A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK\/STAT targeting in T-cell lymphomas","volume":"138","author":"Moskowitz","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jdcr.2025.07.019_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13075-019-1964-1","article-title":"Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations","volume":"21","author":"McInnes","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.jdcr.2025.07.019_bib9","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220686","article-title":"STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection","volume":"220","author":"Sun","year":"2023","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.jdcr.2025.07.019_bib10","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1097-0142(19930401)71:7<2335::AID-CNCR2820710727>3.0.CO;2-D","article-title":"Cyclosporine treatment of refractory T-cell lymphomas","volume":"71","author":"Cooper","year":"1993","journal-title":"Cancer"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625003868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625003868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T21:34:43Z","timestamp":1765316083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625003868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":9,"alternative-id":["S2352512625003868"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.07.019","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression of mycosis fungoides in a patient receiving a Janus kinase inhibitor","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}